(89)Zr-mAb3481 PET for HER3 tumor status assessment during lapatinib treatment

por Pool, Martin, Kol, Arjan, de Jong, Steven, de Vries, Elisabeth G. E., Lub-de Hooge, Marjolijn N., Terwisscha van Scheltinga, Anton G.T.
Publicado 2017

MAPK pathway activity plays a key role in PD‐L1 expression of lung adenocarcinoma cells

por Stutvoet, Thijs S, Kol, Arjan, de Vries, Elisabeth GE, de Bruyn, Marco, Fehrmann, Rudolf SN, Terwisscha van Scheltinga, Anton GT, de Jong, Steven
Publicado 2019

Extracellular domain shedding influences specific tumor uptake and organ distribution of the EGFR PET tracer (89)Zr-imgatuzumab

por Pool, Martin, Kol, Arjan, Lub-de Hooge, Marjolijn N., Gerdes, Christian A., de Jong, Steven, de Vries, Elisabeth G.E., Terwisscha van Scheltinga, Anton G.T.
Publicado 2016

ImmunoPET helps predicting the efficacy of antibody-drug conjugates targeting TENB2 and STEAP1

por Williams, Simon-Peter, Ogasawara, Annie, Tinianow, Jeff N., Flores, Judith E., Kan, David, Lau, Jeffrey, Go, MaryAnn, Vanderbilt, Alexander N., Gill, Herman S., Miao, Li, Goldsmith, Joshua, Rubinfeld, Bonnee, Mao, Weiguang, Firestein, Ron, Yu, Shang-Fan, Marik, Jan, Terwisscha van Scheltinga, Anton G.T.
Publicado 2016